| Oncogene activation: c-raf-1 gene mutations in experimental and naturally occurring tumors. | None |
| pim-1 proto-oncogene expression in anti-CD3-mediated T cell activation is associated with protein kinase C activation and is independent of Raf-1. | None |
| Oncogenic Raf-1 activates p70 S6 kinase via a mitogen-activated protein kinase-independent pathway. | None |
| Exit from G2 phase after 2 Gy gamma irradiation is faster in radiosensitive human cells with high expression of the RAF1 proto-oncogene. | None |
| PKC epsilon functions as an oncogene by enhancing activation of the Raf kinase. | None |
| Differential regulation of Raf-1, A-Raf, and B-Raf by oncogenic ras and tyrosine kinases. | None |
| Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1. | None |
| Induction of cell proliferation in quiescent NIH 3T3 cells by oncogenic c-Raf-1. | None |
| The proto-oncogene Crk-II enhances apoptosis by a Ras-dependent, Raf-1/MAP kinase-independent pathway. | None |
| Mutations of critical amino acids affect the biological and biochemical properties of oncogenic A-Raf and Raf-1. | None |
| Oncogenic raf-1 induces the expression of non-histone chromosomal architectural protein HMGI-C via a p44/p42 mitogen-activated protein kinase-dependent pathway in salivary epithelial cells. | None |